Avocet Bio GmbH

We are beyond excited to share that Avocet Bio has won second place at the BARDA VITAL Global Health Security Symposium today in Berlin! Represented by our CEO and Co-Founder, Elisabeth Zeisberg, this achievement is a testament to our commitment to developing advanced antiviral therapies aimed at protecting lives and communities from the devastating impact of infectious diseases and pandemics. Connecting with Biomedical Advanced Research and Development Authority (BARDA) is of paramount importance for a Europe-based start-up like ours. This relationship enhances our ability to contribute to global health security, providing us with critical insights and opportunities to collaborate on ground-breaking innovations in pandemic preparedness and response. Together, we are paving the way for a safer future. VITAL – A BARDA BAN Hub #DigitalHealth #Antivirals #Therapeutics #GlobalHealth #Biotech #Biomedical #Innovation #HealthSecurity

We are thrilled to introduce the finalists of the VITAL Global Health Security Symposium! Join us this Thursday, June 27 at the Rahel Hirsch Center for Translational Medicine in Berlin to watch these innovative startups take the stage to pitch their groundbreaking solutions in health security and compete for a total prize pool of $45K! 💰 Meet the finalists: 🔬 Avocet Bio GmbH 🔬 Cutanos GmbH 🔬 mbiomics GmbH 🔬 MucosaTec 🔬 NewCo by Grant Knappe 🔬 new/era/mabs 🔬 Sensible Biotechnologies  🔬 Silica Corpora These startups represent the future of global health security, and their innovations have the potential to make a significant impact on public health. Engage with them, along with other industry leaders, experts, and fellow enthusiasts in the health tech space. Want to join? Register here: https://lnkd.in/e8PveJ9j Don't miss out on the opportunity to see the future of global health security unfold! #HealthTech #Innovation #Startups #GlobalHealth #HealthSecurity #DigitalHealth #Vaccines #Therapeutics #Biotech

We are thrilled to announce that we have been selected as a finalist to pitch at the BARDA VITAL Global Health Security Symposium on June 27 in Berlin. This event focuses on visionary advancements in vaccine and therapeutics innovation, and medical countermeasures aimed at enhancing pandemic preparedness and response for a safer future. This is in line with our mission at Avocet Bio supported by SPRIND - Bundesagentur für Sprunginnovationen to develop advanced antiviral therapies to combat viral outbreaks effectively, protecting lives and communities from the devastating impact of infectious diseases and pandemics. Join us as we showcase our solution designed to address critical health challenges. This event brings together the brightest minds in the field, and we are honored to be part of it. Register now ➡️ https://lnkd.in/dH4BWcKF Be a part of the future of healthcare innovation — we hope to see you there! #DigitalHealth #Vaccines #Therapeutics #GlobalHealth #Biotech Biomedical Advanced Research and Development Authority (BARDA) VITAL – A BARDA BAN Hub

Last week, Avocet Bio GmbH together with more than 60 other startups were invited to showcase their disruptive solutions addressing crucial global challenges at the Venture SPRIND - Bundesagentur für Sprunginnovationen event in Berlin. The event brought together #biotech, #deeptech, and #lifescience teams with 200+ #investors. We extend a heartfelt thank you to the team at SPRIND - Bundesagentur für Sprunginnovationen for orchestrating such a dynamic gathering, and for extending their invaluable support to us and fellow startups.

Die Göttinger Professorin Elisabeth Zeisberg ist nicht nur Medizinprofessorin, sie forscht erfolgreich an #RNA-Scheren gegen #Corona|viren, ist erste Dekanin für Transfer und hat ein Start-up gegründet. Ein Porträt. #DNA #Grundlagenforschung #Virus #Genomforschung #Coronavirus Avocet Bio GmbH Universitätsmedizin Göttingen Nils Salaw Sabine Maamari SPRIND - Bundesagentur für Sprunginnovationen Diane Seimetz https://lnkd.in/d9aaydtA

Venture SPRIND is about to start 🚀 30 Challenge teams and 30 more teams from other SPRIND projects will pitch in front of more than 300 investors from all over Europe! Fingers crossed for all of you. I have seen you progress over the course of the Challenges and will thoroughly enjoy watching you rock the stage! 👏 Philippe Vollmer Barbosa Avocet Bio GmbH MucosaTec CPTx SEMRON EcoLogic Computing MacroCarbon enaDyne Carbo Culture Cellbricks AmphiStar C3 Biotech EveryCarbon Insempra Patricia Parlevliet Lars Regestein Manuel Häußler Dr. Mahmoud Masri Ore Energy Unbound Potential Reverion HalioGEN Power and many more! 👏 SPRIND - Bundesagentur für Sprunginnovationen Rafael Laguna de la Vera Christian Bogatu Till Moldenhauer Lisa K. Millies Erik Schäffner Florian Steinmetzger Julia Ebenauer Olav Carlsen Patrick P. Rose https://lnkd.in/dT5zP7w8

Zwei niedersächsische Startups revolutionieren gerade den Kampf gegen Viren! 🦠💥    Das Team CRISPR/Cas13 vom Startup Avocet Bio GmbH und das Projekt iGUARD von der Medizinische Hochschule Hannover und dem Fraunhofer ITEM stehen mit vielversprechenden Ansätzen für neue antivirale Mittel im Kampf gegen Pandemien im Finale der SPRIND-Challenge! iGuard setzt dabei auf maschinelles Lernen, während das Team CRISPR/Cas13 das namensgebende bakterielle Abwehrsystem CRISPR/Cas nutzt.    👉 Was genau hinter den Ansätzen der Zukunft der Virenabwehr steckt, könnt ihr hier nachlesen: https://lnkd.in/e4hZHZxd   #macheneinfachmachen SPRIND - Bundesagentur für Sprunginnovationen

Stellt euch mal vor, wir hätten für jede virale Erkrankung innerhalb von wenigen Wochen ein Gegenmittel, also ein Medikament. Dann wäre so was wie die Corona-Pandemie ziemlich anders verlaufen. Science-Youtuber Jacob Beautemps war an der Georg-August-Universität Göttingen. Dort arbeitet das von Elisabeth Zeisberg gegründete Start-up Avocet Bio GmbH genau daran. Hier ist sein Video: https://lnkd.in/e5vmupPY Das Team um Elisabeth Zeisberg nimmt mit Erfolg seit Herbst 2021 an der SPRIND Challenge "Broad-Spectrum Antivirals" teil: https://lnkd.in/ddu2Pwd Sabine Maamari Diane Seimetz Nils Salaw Jano Costard Erik Schäffner Georgi Apriamashvili Julia Ebenauer Patrick P. Rose

Curious to peek behind the scenes at Avocet Bio and witness the work that goes into developing cutting-edge antivirals? 🎥 𝐂𝐥𝐢𝐜𝐤 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐡𝐞𝐫𝐞:  https://lnkd.in/e5vmupPY We had the pleasure of hosting Jacob Beautemps and the Breaking Lab team who gained insights at the work done to develop CRISPR based antiviral therapeutics. A big shout out to SPRIND - Bundesagentur für Sprunginnovationen for their incredible support and funding, fueling our mission to make a difference in the antiviral landscape. #AvocetBio #BehindTheScenes #BiotechInnovation #Antivirals #SPRIND #BreakingLab #InnovationJourney #ScienceAndDiscovery #WatchNow

🌐 Avocet Bio in the Spotlight 🗞️✨ We are pleased to announce our feature in Göttinger Tageblatt GmbH & Co. KG and Harzkurier this quarter! For more information : https://lnkd.in/eNy2c6am Stay tuned for ongoing updates as Avocet Bio continues to to develop groundbreaking antiviral solutions. Your support is invaluable! 🔬 #AvocetBio #Innovation #PandemicPreparedeness